Gemcitabine/docetaxel - Welcome to a new standard

被引：11

作者：

Fleming, Gini ^{[1
]}

机构：

[1] Univ Chicago, Med Ctr, Hematol Oncol Sect, Chicago, IL 60637 USA

来源：

GYNECOLOGIC ONCOLOGY | 2008年 / 109卷 / 03期

关键词：

D O I：

10.1016/j.ygyno.2008.04.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：313 / 315

页数：3

共 19 条

[1]

DADAMO DR, 2007, J CLIN ONCOL S, V25, pS545

[2] Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study [J].

Gallup, DG ;

Blessing, JA ;

Andersen, W ;

Morgan, MA .

GYNECOLOGIC ONCOLOGY, 2003, 89 (01) :48-51

[3] Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine lelomyosarcoma: A Gynecologic Oncology Group phase II trial [J].

Hensley, Martee L. ;

Blessing, John A. ;

Mannel, Robert ;

Rose, Peter G. .

GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :329-334

[4] Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study [J].

Hensley, Martee L. ;

Blessing, John A. ;

DeGeest, Koen ;

Abulafia, Ovadia ;

Rose, Peter G. ;

Homesley, Howard D. .

GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :323-328

[5] Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma:: a study by the EORTC Soft Tissue and Bone Sarcoma Group [J].

Judson, I ;

Radford, JA ;

Harris, M ;

Blay, JY ;

van Hoesel, Q ;

le Cesne, A ;

van Oosterom, AT ;

Clemons, MJ ;

Kamby, C ;

Hermans, C ;

Whittaker, J ;

di Paola, ED ;

Verweij, J ;

Nielsen, S .

EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) :870-877

[6] Systemic therapy for advanced uterine sarcoma: A systematic review of the literature [J].

Kanjeekal, S ;

Chambers, A ;

Fung, MFK ;

Verma, S .

GYNECOLOGIC ONCOLOGY, 2005, 97 (02) :624-637

[7] Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOC) Study [J].

Look, KY ;

Sandler, A ;

Blessing, JA ;

Lucci, JA ;

Rose, PG .

GYNECOLOGIC ONCOLOGY, 2004, 92 (02) :644-647

[8] Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas [J].

Maki, Robert G. ;

Wathen, J. Kyle ;

Patel, Shreyaskumar R. ;

Priebat, Dennis A. ;

Okuno, Scott H. ;

Samuels, Brian ;

Fanucchi, Michael ;

Harmon, David C. ;

Schuetze, Scott M. ;

Reinke, Denise ;

Thall, Peter F. ;

Benjamin, Robert S. ;

Baker, Laurence H. ;

Hensley, Martee L. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2755-2763

[9] Gemcitabine and docetaxel in metastatic sarcoma: Past, present, and future [J].

Maki, Robert G. .

ONCOLOGIST, 2007, 12 (08) :999-1006

[10]

Pautier P, 2000, CANCER, V88, P1425, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1425::AID-CNCR21>3.0.CO

← 1 2 →